Give And Get Campaign Results – The Gap Give and Get Campaign, which benefited The Leukemia & Lymphoma Society (LLS), was held from July 30 to August 2. The Gap is donating 5 percent of its sales during this period to the LLS, raising a total of $500,000 to support blood cancer research. For more information, please visit the LLS Web site.

Royal Hospital In Oman Setting Up Stem Cell Bank And Transplantation Unit – The Royal Hospital in Oman is in the final stages of establishing a stem cell bank and a transplantation unit. The stem cell bank will be ready by the end of 2009, and the transplantation unit will be completed by September 2010. Currently, building modifications are under way to accommodate the stem cell bank. The equipment for the stem cell bank has been selected and will be installed once the building modifications are completed. For more information, please visit the Zawya article.

Keryx To Present Overview Of Leading Drug Candidates – On September 9 at 2:50 p.m., Keryx will present an overview of its leading drugs at the Rodman & Renshaw Annual Global Investment Conference in New York City. Ron Bentsur, Chief Executive Officer of Keryx, will give the presentation on the lead drug candidates perifosine (KRX-0401) and Zerenex (ferric citrate). Perifosine is currently in trials as an oral anti-cancer drug that affects the growth and death of multiple myeloma cells, while Zerenex is in trials as a treatment for elevated phosphate levels in patients with severe kidney disease. The presentation will be available live by audio webcast at the Keryx Web site. For more information, please visit the Keryx press release.

For a more detailed listing of myeloma related events, please check the Myeloma Beacon Events Calendar.